| |
| |
| Exchange: |
OTC Bulletin Board |
| Security
Type: |
Common |
| Shares
Out: |
65,581,000 |
| Market
Cap: |
41.97(M) |
| Last
Volume: |
0 |
Avg
Vol: |
0 |
| 52
Week Range: |
$0.64 - $0.64 |
|
| Level
I Sector: |
N/A |
| Level
II Sector: |
N/A |
| Level
III Sector: |
N/A |
|
Member Indexes:
|
Rankings:
|
|
| Insider 3 Months : - |
| Insider 6 Months : - |
| Insider 3/6 Months : - |
|
| Guru Rank Number : - |
| Guru Rank Value : - |
| Guru Occurances : - |
|
|
|
|
|
| |
|
Company Profile Predictive Oncology operates in several primary business areas, including: the application of artificial intelligence (AI) in its precision medicine business, to provide AI-driven predictive models of tumor drug response to improve clinical outcomes for patients and to assist pharmaceutical, diagnostic, and biotech industries in the development of new personalized drugs and diagnostics; the creation and development of tumor-specific 3D cell culture models driving accurate prediction of clinical outcomes; and the production of the U.S. Food and Drug Administration-cleared STREAMWAY® System for automated, direct-to-drain medical fluid disposal and associated products.
|
|
|
D/I:
|
|
|
D
is for direct shares.
I is
for indirect shares.
D/I
refers to the Direct or Indirect
shares traded vs. held. |
|
|
|
Forms:
|
|
|
A
Form 4 is a form filed
by an insider to indicate a change
in ownership.
A Form
3 is a form filed by
an insider to indicate an
initial ownership of a security. |
|
|
|
3m +/-:
|
|
|
|
This
represents the company's 3 month
price change. The initial price
is based on the closing price
of the stock on the day the transaction
took place. Purchases & sales
are viewed as long & short
positions respectively.
|
|
|
|
Actions:
|
|
|
| B |
Buy |
| S |
Sell |
| OE |
Option
Exercised |
| A |
Acquired |
| D |
Disposed |
| AB |
Automatic
Buy |
| AS |
Automatic
Sell |
| IO |
Initial
Ownership |
|
|
|
|
Download:
|
|
|
Download only Transactions
Forms. (Default)
Download
only Summary Infomation.
Download
both Transactions and Summary Data
|
|
|
|
|
| |
| |
Summary (Direct Transactions Only)  |
3 Months |
6 Months |
12 Months |
24 Months |
| Total Shares Bought |
0 |
0 |
0 |
32,345 |
| Total Buy Value |
$0 |
$0 |
$0 |
$14,577 |
| Total People Bought |
0 |
0 |
0 |
3 |
| Total Buy Transactions |
0 |
0 |
0 |
5 |
| Total Shares Sold |
0 |
0 |
10,000 |
10,000 |
| Total Sell Value |
$0 |
$0 |
$30,387 |
$30,387 |
| Total People Sold |
0 |
0 |
1 |
1 |
| Total Sell Transactions |
0 |
0 |
1 |
1 |
| End Date |
2024-02-25 |
2023-11-24 |
2023-05-26 |
2022-05-26 |
|
| Filer's Name |
Relation Title |
Off-Dir-10% |
Tran. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
  Vennare Raymond F |
Director |
– • – |
2021-10-01 |
4 |
A |
$0.00 |
$0 |
D/D |
4,512 |
9,512 |
|
- |
|
| Jenkins Christina Lee Md |
Director |
– • – |
2021-10-01 |
4 |
A |
$0.00 |
$0 |
D/D |
4,512 |
19,436 |
|
- |
|
| Nuzum Charles Lee Sr |
Director |
– • – |
2021-10-01 |
4 |
A |
$0.00 |
$0 |
D/D |
6,265 |
33,859 |
|
- |
|
| Engle J Melville |
CEO and Chairman |
• • – |
2021-10-01 |
4 |
A |
$0.00 |
$0 |
D/D |
4,512 |
23,465 |
|
- |
|
| St. Clair Gregory Sr |
Director |
– • – |
2021-10-01 |
4 |
A |
$0.00 |
$0 |
D/D |
6,265 |
31,845 |
|
- |
|
| Chung-Welch Nancy |
Director |
– • – |
2021-10-01 |
4 |
A |
$0.00 |
$0 |
D/D |
4,512 |
24,093 |
|
- |
|
| Handley Daniel E |
Director |
– • – |
2021-10-01 |
4 |
A |
$0.00 |
$0 |
D/D |
4,512 |
23,465 |
|
- |
|
| Myers Robert L |
Chief Financial Officer |
• – – |
2021-09-23 |
4 |
D |
$1.13 |
$11,526 |
D/D |
(10,200) |
23,211 |
|
- |
|
| Myers Robert L |
Chief Financial Officer |
• – – |
2021-09-23 |
4 |
OE |
$1.13 |
$37,667 |
D/D |
33,334 |
33,411 |
|
- |
|
| Vennare Raymond F |
Director |
– • – |
2021-09-13 |
4 |
A |
$0.00 |
$0 |
D/D |
5,000 |
5,000 |
|
- |
|
| Nuzum Charles Lee Sr |
Director |
– • – |
2021-07-01 |
4 |
A |
$0.00 |
$0 |
D/D |
13,995 |
27,594 |
|
- |
|
| Jenkins Christina Lee Md |
Director |
– • – |
2021-07-01 |
4 |
A |
$0.00 |
$0 |
D/D |
9,924 |
14,924 |
|
- |
|
| Engle J Melville |
CEO and Chairman |
• • – |
2021-07-01 |
4 |
A |
$0.00 |
$0 |
D/D |
9,924 |
18,953 |
|
- |
|
| Handley Daniel E |
Director |
– • – |
2021-07-01 |
4 |
A |
$0.00 |
$0 |
D/D |
9,924 |
18,953 |
|
- |
|
| St. Clair Gregory Sr |
Director |
– • – |
2021-07-01 |
4 |
A |
$0.00 |
$0 |
D/D |
13,995 |
25,580 |
|
- |
|
| Chung-Welch Nancy |
Director |
– • – |
2021-07-01 |
4 |
A |
$0.00 |
$0 |
D/D |
9,924 |
19,581 |
|
- |
|
| Jenkins Christina Lee Md |
Director |
– • – |
2021-04-21 |
4 |
A |
$0.00 |
$0 |
D/D |
5,000 |
5,000 |
|
- |
|
| Handley Daniel E |
Director |
– • – |
2021-04-01 |
4 |
A |
$0.00 |
$0 |
D/D |
4,959 |
9,029 |
|
- |
|
| Gabriel Richard L |
Director |
– • – |
2021-04-01 |
4 |
A |
$0.00 |
$0 |
D/D |
4,959 |
17,029 |
|
- |
|
| Chung-Welch Nancy |
Director |
– • – |
2021-04-01 |
4 |
A |
$0.00 |
$0 |
D/D |
4,959 |
9,657 |
|
- |
|
| Engle J Melville |
CEO and Chairman |
• • – |
2021-04-01 |
4 |
A |
$0.00 |
$0 |
D/D |
4,959 |
9,029 |
|
- |
|
| St. Clair Gregory Sr |
Director |
– • – |
2021-04-01 |
4 |
A |
$0.00 |
$0 |
D/D |
6,887 |
11,585 |
|
- |
|
| Nuzum Charles Lee Sr |
Director |
– • – |
2021-04-01 |
4 |
A |
$0.00 |
$0 |
D/D |
6,887 |
13,599 |
|
- |
|
| Schwartz Carl I. |
Chief Executive Officer |
• • – |
2021-02-24 |
4 |
A |
$1.43 |
$143,573 |
D/D |
100,401 |
1,711,742 |
|
- |
|
| Schwartz Carl I. |
Chief Executive Officer |
• • • |
2020-10-22 |
4 |
AS |
$0.85 |
$544 |
D/D |
(640) |
1,611,341 |
|
- |
|
225 Records found
|
|
Page 4 of 9 |
|
|
